Researcher.Life Logo

Journal of Scleroderma and Related Disorders : Impact Factor & More

eISSN: 2397-1991pISSN: 2397-1983

Key Metrics

CiteScore
4.8
SJR
Q2Immunology
SNIP
0.61
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Journal of Scleroderma and Related Disorders

Journal of Scleroderma and Related Disorders Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher SAGE PUBLICATIONS LTD
Language English
Frequency Tri-annual
General Details
LanguageEnglish
FrequencyTri-annual
Publication Start Year2016
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Journal of Scleroderma and Related Disorders ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Journal of Scleroderma and Related Disorders

AhR agonist Ficz modulates T follicular helper cells and ameliorates skin fibrosis in a bleomycin-induced SSc mouse model
  • 26 May 2026
  • Journal of Scleroderma and Related Disorders
Influence of comorbidities and patient demographics on Raynaud\u2019s symptom characteristics: implications for diagnosis and management
  • 26 May 2026
  • Journal of Scleroderma and Related Disorders
Are we ready to predict progressive disease in juvenile systemic sclerosis?
  • 26 May 2026
  • Journal of Scleroderma and Related Disorders
Palliative care in systemic sclerosis: incorporating advance care planning into longitudinal care
  • 26 May 2026
  • Journal of Scleroderma and Related Disorders
Lips in health and in systemic sclerosis: relevant physiology, pathogenesis, existing therapeutic approaches and unmet needs
  • 26 May 2026
  • Journal of Scleroderma and Related Disorders
What is the treatment pattern of juvenile systemic sclerosis? Results from an international cohort
  • 26 May 2026
  • Journal of Scleroderma and Related Disorders
AhR agonist Ficz modulates T follicular helper cells and ameliorates skin fibrosis in a bleomycin-induced SSc mouse model
  • 26 May 2026
  • Journal of Scleroderma and Related Disorders
Influence of comorbidities and patient demographics on Raynaud\u2019s symptom characteristics: implications for diagnosis and management
  • 26 May 2026
  • Journal of Scleroderma and Related Disorders
Are we ready to predict progressive disease in juvenile systemic sclerosis?
  • 26 May 2026
  • Journal of Scleroderma and Related Disorders
Palliative care in systemic sclerosis: incorporating advance care planning into longitudinal care
  • 26 May 2026
  • Journal of Scleroderma and Related Disorders
Lips in health and in systemic sclerosis: relevant physiology, pathogenesis, existing therapeutic approaches and unmet needs
  • 26 May 2026
  • Journal of Scleroderma and Related Disorders
What is the treatment pattern of juvenile systemic sclerosis? Results from an international cohort
  • 26 May 2026
  • Journal of Scleroderma and Related Disorders

FAQs on Journal of Scleroderma and Related Disorders